Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Resilia tissue developed by Edwards Lifesciences linked to long-term benefits
Researchers tracked nearly 1,000 SAVR patients, presenting eight-year data at the Heart Valve Society’s annual meeting in Cairo, Egypt.
Family of heart patient who died awarded $45M after suing health system for negligence
The 55-year-old patient woke up experiencing chest pain one morning and an ambulance was called. He was dead just a few hours later. His family's lawsuit argued that delays in care, communication errors and other issues were directly responsible for his death.
AI newswatch: Lifecyle AI oversight, data matters, AI vs. animals, more
AI may finally end the paper chase caused by prior authorization. Or it may worsen it.
Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women
Coronary artery disease is both underdiagnosed and undertreated in women, and they often receive less guideline-recommended care than men. Why do these disparities persist? And what can today’s healthcare providers do to bring about change?
AI has come a long way in healthcare, still has a long way to go: Research recap
As AI continues its march through healthcare organizations around the world, the notion that it will replace the sector’s human workers fades but does not disappear.

More financial challenges ahead for not-for-profit hospitals

"Margins are not expected to return to pre-pandemic levels for quite some time," according to a new report.

Cardiologists warn Biden administration that new policies could put PAD patients at risk

SCAI and the Association of Black Cardiologists have joined forces to share a simple message: PAD patients would be negatively impacted by new CMS proposals.

High costs limit the value of dapagliflozin, empagliflozin as heart failure treatments

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more.

Ulcerative colitis AI identifies activity vs. remission, predicts future flareups

Researchers across the pond have developed and externally validated an AI model that can predict flareups of ulcerative colitis.

Atrium Health and Best Buy Health Partner to Improve Experience When Receiving Care at Home

Best Buy makes healthcare play with Atrium Health partnership

The new collaboration aims to enable providers to provide hospital-level care at home, leaning on Atrium Health’s telemedicine services and Best Buy Health’s ongoing care at home platform.

Top 10 hospitals in the world for 2023

The United States has some of the best hospitals in the world, including the No. 1 overall best hospital, according to a recent ranking of hospitals by Newsweek.

Diabetes and obesity rates in the US are climbing

Reviewing the records of nearly 13,000 young adults, researchers have found several cardiovascular risk factors increased in prevalence over time.

UnityPoint Health to merge with Presbyterian Healthcare Services

Both organizations signed a letter of intent to merge in a deal where both would keep their brands and continue to deliver care locally.

Care Delivery

Resilia tissue developed by Edwards Lifesciences linked to long-term benefits

Family of heart patient who died awarded $45M after suing health system for negligence

AI newswatch: Lifecyle AI oversight, data matters, AI vs. animals, more

Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women

AI has come a long way in healthcare, still has a long way to go: Research recap